The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter

被引:104
作者
Poma, EE
Kowalik, TF
Zhu, LA
Sinclair, JH
Huang, ES
机构
[1] UNIV N CAROLINA, DEPT MICROBIOL & IMMUNOL, CHAPEL HILL, NC 27599 USA
[2] UNIV N CAROLINA, DEPT MED, CHAPEL HILL, NC 27599 USA
[3] DUKE UNIV, MED CTR, HOWARD HUGHES MED INST, DEPT GENET, DURHAM, NC 27710 USA
[4] MASSACHUSETTS GEN HOSP, CTR CANC, CHARLESTOWN, MA 02129 USA
[5] UNIV CAMBRIDGE, DEPT MED, CAMBRIDGE CB2 2QQ, ENGLAND
关键词
D O I
10.1128/JVI.70.11.7867-7877.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Rb-related p107 protein has been implicated as an important control element in proper cell cycle progression. The p107 protein is thought to restrict cellular proliferation in part through its interaction with the E2F family of transcription factors and is, therefore, a specific target for regulation by several DNA viruses. Here, we demonstrate that p107 protein levels are induced in a biphasic manner in human fibroblasts during productive infection by the human cytomegalovirus (HCMV). Expression patterns of p107 protein levels during HCMV infection of human embryonic lung cells (HELs) demonstrate a sustained induction from early to late times of infection. We also demonstrate that the HCMV immediate-early protein IE1-72 complexes in vivo with the p107 protein and that this interaction can be reconstituted in an in vitro system by using reticulocyte-translated protein. Our data demonstrate that the interaction between p107 and the IE1-72 protein occurs at times of infection that temporally match the second tier of p107 protein induction and the phosphorylation pattern of the IE1-72 protein. Furthermore, we show here that the ability of p107 to transcriptionally repress E2F-responsive promoters can he overcome by expression of the IE1-72 protein. This effect appears to be specific, since the IE1-72 protein is not capable of relieving Rb-mediated repression of an E2F-responsive promoter. Finally, our data demonstrate that HCMV infection can induce cellular proliferation in quiescent cells and that IE1-72 expression alone can, to a degree, drive a similar progression through the cell cycle. These data suggest that IE1-72-mediated transactivation of E2F-responsive promoters through alleviation of p107 transcriptional repression may play a key role in the cell cycle progression stimulated by HCMV infection.
引用
收藏
页码:7867 / 7877
页数:11
相关论文
共 97 条
[81]   NUCLEAR FACTOR E2F MEDIATES BASIC TRANSCRIPTION AND TRANS-ACTIVATION BY E1A OF THE HUMAN MYC PROMOTER [J].
THALMEIER, K ;
SYNOVZIK, H ;
MERTZ, R ;
WINNACKER, EL ;
LIPP, M .
GENES & DEVELOPMENT, 1989, 3 (04) :527-536
[82]   E2F MEDIATES DIHYDROFOLATE-REDUCTASE PROMOTER ACTIVATION AND MULTIPROTEIN COMPLEX-FORMATION IN HUMAN CYTOMEGALOVIRUS-INFECTION [J].
WADE, M ;
KOWALIK, TF ;
MUDRYJ, M ;
HUANG, ES ;
AZIZKHAN, JC .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (10) :4364-4374
[83]   A 10-BASE-PAIR ELEMENT OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT (LTR) IS AN ABSOLUTE REQUIREMENT FOR TRANSACTIVATION BY THE HUMAN CYTOMEGALOVIRUS 72-KILODALTON IE1 PROTEIN BUT CAN BE COMPENSATED FOR BY OTHER LTR REGIONS IN TRANSACTIVATION BY THE 80-KILODALTON IE2 PROTEIN [J].
WALKER, S ;
HAGEMEIER, C ;
SISSONS, JGP ;
SINCLAIR, JH .
JOURNAL OF VIROLOGY, 1992, 66 (03) :1543-1550
[84]  
WEINBERG RA, 1992, CANCER SURV, V12, P43
[85]  
WEINBERG RA, 1995, TUMOR SUPPRESSOR GEN, V375, P812
[86]   RETINOBLASTOMA PROTEIN SWITCHES THE E2F SITE FROM POSITIVE TO NEGATIVE ELEMENT [J].
WEINTRAUB, SJ ;
PRATER, CA ;
DEAN, DC .
NATURE, 1992, 358 (6383) :259-261
[87]   MECHANISM OF ACTIVE TRANSCRIPTIONAL REPRESSION BY THE RETINOBLASTOMA PROTEIN [J].
WEINTRAUB, SJ ;
CHOW, KNB ;
LUO, RX ;
ZHANG, SH ;
HE, S ;
DEAN, DC .
NATURE, 1995, 375 (6534) :812-815
[88]   CELLULAR TARGETS FOR TRANSFORMATION BY THE ADENOVIRUS E1A PROTEINS [J].
WHYTE, P ;
WILLIAMSON, NM ;
HARLOW, E .
CELL, 1989, 56 (01) :67-75
[89]   2 REGIONS OF THE ADENOVIRUS EARLY REGION 1A-PROTEINS ARE REQUIRED FOR TRANSFORMATION [J].
WHYTE, P ;
RULEY, HE ;
HARLOW, E .
JOURNAL OF VIROLOGY, 1988, 62 (01) :257-265
[90]  
WOLF DA, 1995, ONCOGENE, V10, P2067